[go: up one dir, main page]

GB201721604D0 - An oral liquid pharmaceutical composition of lamotrigine` - Google Patents

An oral liquid pharmaceutical composition of lamotrigine`

Info

Publication number
GB201721604D0
GB201721604D0 GBGB1721604.5A GB201721604A GB201721604D0 GB 201721604 D0 GB201721604 D0 GB 201721604D0 GB 201721604 A GB201721604 A GB 201721604A GB 201721604 D0 GB201721604 D0 GB 201721604D0
Authority
GB
United Kingdom
Prior art keywords
lamotrigine
pharmaceutical composition
oral liquid
liquid pharmaceutical
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1721604.5A
Other versions
GB2569615A (en
GB2569615B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syri Ltd
Original Assignee
Syri Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syri Ltd filed Critical Syri Ltd
Priority to GB1721604.5A priority Critical patent/GB2569615B/en
Publication of GB201721604D0 publication Critical patent/GB201721604D0/en
Publication of GB2569615A publication Critical patent/GB2569615A/en
Application granted granted Critical
Publication of GB2569615B publication Critical patent/GB2569615B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
GB1721604.5A 2017-12-21 2017-12-21 An oral liquid pharmaceutical composition of lamotrigine Expired - Fee Related GB2569615B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1721604.5A GB2569615B (en) 2017-12-21 2017-12-21 An oral liquid pharmaceutical composition of lamotrigine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1721604.5A GB2569615B (en) 2017-12-21 2017-12-21 An oral liquid pharmaceutical composition of lamotrigine

Publications (3)

Publication Number Publication Date
GB201721604D0 true GB201721604D0 (en) 2018-02-07
GB2569615A GB2569615A (en) 2019-06-26
GB2569615B GB2569615B (en) 2021-12-22

Family

ID=61131695

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1721604.5A Expired - Fee Related GB2569615B (en) 2017-12-21 2017-12-21 An oral liquid pharmaceutical composition of lamotrigine

Country Status (1)

Country Link
GB (1) GB2569615B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2628595A (en) * 2023-03-29 2024-10-02 Orbit Pharma Ltd A biphasic liquid pharmaceutical composition of an anticonvulsant drug and the process of preparing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009061513A1 (en) * 2007-11-09 2009-05-14 Thar Pharmaceuticals Crystalline forms of lamotrigine
CN104873461A (en) * 2015-06-24 2015-09-02 万特制药(海南)有限公司 Preparation method for lamotrigine oral solution
WO2018071547A1 (en) * 2016-10-11 2018-04-19 Aucta Pharmaceuticals Powder for oral suspension containing lamotrigine
WO2018142336A1 (en) * 2017-02-03 2018-08-09 Jubilant Generics Limited Lamotrigine suspension dosage form

Also Published As

Publication number Publication date
GB2569615A (en) 2019-06-26
GB2569615B (en) 2021-12-22

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
IL258082B (en) Bezimidazole derivatives and pharmaceutical compositions containing them
PT3565550T (en) Pharmaceutical compositions comprising meloxicam
SMT202500036T1 (en) Pharmaceutical compositions comprising meloxicam
IL271657A (en) Pharmaceutical compositions
IL271986A (en) Pharmaceutical composition
ZA201802199B (en) Pharmaceutical compositions of il-2
ZA201907313B (en) Stable liquid pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
HUE068810T2 (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
IL272419A (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
GB201713660D0 (en) Pharmaceutical compositions
GB201705305D0 (en) Pharmaceutical compositions
GB201705304D0 (en) Pharmaceutical compositions
PL3646867T3 (en) Pharmaceutical composition
GB201705306D0 (en) Pharmaceutical compositions
IL267279A (en) Pharmaceutical formulations of suvorexant
GB201718468D0 (en) Stable liquid pharmaceutical compositions of bortezomb
ZA201804588B (en) Pharmaceutical formulations for the treatment of diabetes
GB2569615B (en) An oral liquid pharmaceutical composition of lamotrigine
GB201714241D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB201715881D0 (en) New pharmaceutical compositions
GB201715404D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220322